Adaptimmune Therapeutics plc ADAP

Quarterly report 2025-Q2
added 08-13-2025

Adaptimmune Therapeutics plc DIO Ratio 2011-2026 | ADAP

Quarterly DIO Ratio Adaptimmune Therapeutics plc

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
423	990	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
990	423	706

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Cerus Corporation CERS	213	$ 2.72	33.99 %	$ 518 M	USA
	ACADIA Pharmaceuticals ACAD	295	$ 21.95	-2.23 %	$ 3.64 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Edesa Biotech EDSA	184	$ 17.59	-3.75 %	$ 56.2 M	USA
	Eiger BioPharmaceuticals EIGR	33.5 K	-	-9.21 %	$ 2.55 M	USA